CEO Edward Ludwig

Forlenza will assume additional responsibility as Chairman of the Board, effective July 1, 2012, following his appointment by the Board of Directors. Mr. Forlenza will succeed Edward J. Ludwig, who is retiring from BD. "Vince has demonstrated strong ...  

The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics ? strong fundamentals and a valuation that looks inexpensive. Becton, Dickinson and Co. (NYSE: BDX) presently has an above average rank, in the top 50% of the coverage universe, which suggests it is among the top most "interesting...  

FRANKLIN LAKES, N.J. and OLATHE, Kan., May 21, 2012 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Heart to Heart International, a humanitarian medical aid nonprofit organization, are ...  

US - NJ - Franklin Lakes, • B.A. or B.S. degree in Business, Marketing, Healthcare or a related field; MBA highly preferred • Minimum of 6 years of business experience in the life science industry; Diabetes Care and Insulin  

CHICAGO, April 16, 2012 /PRNewswire/ --  Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include...  

A divided panel of the U.S Court of Appeals for the Federal Circuit affirmed the TTAB's decision (TTABlogged here) refusing registration, on the ground of functionality, of the product configuration shown below for a closure cap for blood collection tubes. The majority ruled that the Board had not committed legal error by weighing the functional and non-functional features of the design against each other in order to determine whether the...  

By Jason Rantanen Therasense, Inc. v. Becton, Dickinson and Company (N.D. Cal. 2012) Download 2012-03-28 Therasense v Becton Dickinson Following the Federal Circuit's remand in Therasense v. Becton Dickinson, the district court has concluded that Patent No. 5,820,551 is unenforceable...  

The stock is trading at a 16.3% discount to its calculated fair value ... A Star was earned since the Free Cash Flow payout ratio was less than 60% and there were no negative Free Cash Flows over the last 10 years. BDX earned a Star for having an ...  

Revenue rose 3.6% to $1.99 billion, or 4.6% stripping out currency ... 04/10 BD Signs Agreement to Sell Majority of Discovery Labware Unit Advanced Bioproces.. 04/10 DJ Corning To Buy Bulk Of Becton Dickinson's Lab Products 04/10 DJ Corning To Buy Bulk ...  

For the quarter ended March 31 (Q2), Becton, Dickinson and beat expectations on revenues and met expectations on earnings per share. Compared to the prior-year quarter, revenue increased and GAAP earnings per share didn't change. Margins dropped ...  

Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Covidien ( COV), General Electrical ( GE), Becton, Dickinson and Company ...  

Corning Inc., world's largest maker of LCD glass, is buying a majority of Becton, Dickinson and Co.'s Discovery Labware division for about $730 million in order to bolster its life sciences offerings.  

Medical supplies giant Becton Dickinson (BDX) is selling most of its Discovery Labware unit to Corning (GLW) for $730 million. In its statement, Corning said the acquisition will bring about $235 million in annual revenue and "enhance its broad portfolio ...  

Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems ... and cell culture media supplements for biopharmaceutical manufacturing. Becton serves healthcare institutions, life ...  

April 10 (Reuters) - Specialty glass maker Corning Inc said it will buy the majority of Becton Dickinson & Co's Discovery Labware unit for about $730 million in cash, to add drug-discovery and lab...  

Becton, Dickinson and Company (NYSE:BDX) recently revealed that it inked a definitive agreement to sell off its Discovery Labware sub ... The rising demand for safety-needle products (with higher price points and margins) was the primary driver ...  

Becton, Dickinson and Company ( BDX) recently revealed that it inked a definitive agreement to sell off its Discovery Labware sub ... The rising demand for safety-needle products (with higher price points and margins) was the primary driver ...  

NEW YORK (MarketWatch) -- Corning Inc. said Tuesday it'll pay $730 million in cash to buy the majority of the BD Biosciences - Discovery Labware unit of Becton Dickinson & Co. . Corning expects to close the deal later this year. Corning said the acquisition will add to its effort to meet its $10 billion revenue target in the next few years. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit...  

CORNING (IT-Times) - Der weltgrößte LCD-Glashersteller Corning übernimmt die Mehrheit an der Becton, Dickinson and Co Einheit Discovery Labware für rund 730 Mio. US-Dollar in bar, um seine Forschun...  

April 10 (Reuters) - Specialty glass maker Corning Inc said it will buy the majority of Becton Dickinson & Co's biosciences unit for about $730 million in cash, to add drug-discovery and lab...  

Corning agreed on Tuesday to buy the majority of Becton Dickinson’s biosciences ... They include businesses that make plastic lab tools like Petri dishes and flasks and equipment to grow cells. “The Discovery Labware unit’s extensive ...  

Paul, Weiss, Rifkind, Wharton & Garrison LLP | Jacqueline Rubin Named Rising ...Linex Legal (press release) (registration)... one of four attorneys under the age of 40 in the healthcare practice area. The March 21 article highlights Jacqui's work in a successful whistleblower case for Becton, Dickinson and Co., the cases she has tried for IBM Corp., and her pro bono practice.and more »